Detalles de la búsqueda
1.
Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series.
J Enzyme Inhib Med Chem
; 35(1): 109-117, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31687859
2.
Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation.
Molecules
; 25(10)2020 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32443462
3.
Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes.
J Enzyme Inhib Med Chem
; 33(1): 1064-1073, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29909747
4.
New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs.
Eur J Med Chem
; 127: 691-702, 2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27823879
5.
New ways to image and target tumour hypoxia and its molecular responses.
Radiother Oncol
; 116(3): 352-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26324018
6.
Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates.
J Med Chem
; 56(21): 8512-20, 2013 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24128000
7.
Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
Radiother Oncol
; 108(3): 523-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23849171
Resultados
1 -
7
de 7
1
Próxima >
>>